News & Events
Latest
Finding a surrogate measure of efficacy should speed regulators' decisions on vaccine approval even without large placebo-controlled studies, which could be impracticable to carry out if vaccines become widely available, said Peter Gilbert, a researcher at Fred Hutchinson and an author of the recent study.
Eagerly anticipated new research pinpoints antibodies scientists can test for to see if a COVID-19 vaccine is effective. These "correlates of protection" could speed the development of new vaccines or boosters without requiring the enormous clinical trials used to create the first COVID-19 vaccines. This is "the Holy Grail" in terms of vaccines, and one that hasn't yet been set for the virus that causes COVID-19, said Peter Gilbert, co-author of the study posted August 10 to medRxiv and a UW research professor of biostatistics.
Biostatistics faculty Lianne Sheppard, Marco Carone and Adam Szpiro were members of a UW Department of Environmental & Occupational Health Sciences (DEOHS) research team that found Puget Sound residents exposed to higher levels of fine particulate air pollution over a 10-year period had a greater risk of developing dementia.
The U.S. National Science Foundation has announced 11 new artificial-intelligence research institutes, including one led by the University of Washington. Daniela Witten, professor of biostatistics and statistics, is part of the UW-led AI Institute for Dynamic Systems that will focus on fundamental AI and machine learning theory, algorithms and applications for real-time learning and control of complex dynamic systems, which describe chaotic situations where conditions are constantly shifting and hard to predict.